The AAS Impact
1081
Monday, 9th September, 2019
This DELTAS Africa case study looks at drug resistance to antiretroviral treatments in Africa and explores efforts by researchers from Botswana to develop a cost-effective HIV drug resistance assay.
Fellow's Login
I cant remember my password